Principal Scientist, Clinical Pharmacology
Genentech
Dr. Hardik Mody is currently a Principal Scientist at Genentech within the Clinical Pharmacology department, with over 6-7 years of drug development experience. As a Clinical Pharmacology lead, he is guiding Clin Pharm strategies, supporting regulatory submissions, performing M&S analysis for novel modalities (such as cell therapy), biologics (such as T-cell engagers), small molecules within oncology and non-oncology therapeutic areas. He has previously worked in the Translational PK/PD group at Janssen, supporting early discovery, preclinical and early clinical development of therapeutic biologics in oncology and other therapeutic areas. He has also served as the PK/PD SME (Subject Matter Expert) for cell and gene therapies within his organization. He has authored >20 peer-reviewed scientific journal articles and several scientific abstracts in the field of PK/PD, oncology, and drug delivery and has been an invited speaker at external scientific conferences. He has received MS and PhD from the Ohio State University in Pharmaceutical Sciences and Postdoctoral experience from the Center for Pharmacometrics & Systems Pharmacology, University of Florida.
Disclosure(s): No financial relationships to disclose
Sunday, November 10, 2024
9:00 AM – 10:15 AM MST
Sunday, November 10, 2024
9:25 AM – 9:50 AM MST
